Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose
暂无分享,去创建一个
[1] P. Seth,et al. Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018 , 2020, MMWR. Morbidity and mortality weekly report.
[2] V. Arora,et al. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose , 2019, JAMA network open.
[3] L. Feldman,et al. A Cross-sectional Survey Using Clinical Vignettes to Examine Overdose Risk Assessment and Willingness to Prescribe Naloxone , 2018, Journal of General Internal Medicine.
[4] P. Coffin,et al. Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. , 2018, Preventive medicine.
[5] Lawrence Scholl,et al. Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017 , 2018, MMWR. Morbidity and mortality weekly report.
[6] E. Vittinghoff,et al. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain , 2016, Annals of Internal Medicine.
[7] R. Chou,et al. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.